SESANA MARIA SILVIA

Room: 
U28, Piano: P02, Stanza: 2009
Via Follerau SN - 20854 VEDANO AL LAMBRO
Role: 
Administrative-Technical Staff
Telephone: 
0264488228

Publications

  • Taiarol, L., Formicola, B., Magro, R., Sesana, S., & Re, F. (2020). An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy. NANOMEDICINE, 1-11.
  • Gregori, M., Taylor, M., Salvati, E., Re, F., Mancini, S., Balducci, C., et al. (2017). Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide. NANOMEDICINE, 13(2), 723-732.
  • Zoia, C., Conti, E., Cereda, D., Rodriguez-Menendez, V., Andreoni, S., Gregori, M., et al. (2016). THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS. JOURNAL OF ALZHEIMER'S DISEASE.
  • Gregori, M., Orlando, A., Re, F., Sesana, S., Nardo, L., Salerno, D., et al. (2016). Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes. JOURNAL OF PHARMACEUTICAL SCIENCES, 105(1), 276-283.
  • Zoia, C., Conti, E., Ulisse, A., Rodriguez-Menendez, V., Gregori, M., Sesana, M.S., et al. (2015). Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease. In abstract book.